Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech Services Conference
| NYXH Stock | USD 10.39 0.44 4.06% |
Under 62% of Nyxoah's investor base is looking to short. The analysis of overall sentiment of trading Nyxoah stock suggests that many investors are alarmed at this time. Nyxoah's investing sentiment shows overall attitude of investors towards Nyxoah.
Nyxoah |
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech Services Conference Mont-Saint-Guibert, Belgium February 29, 2024, 1030pm CET 430pm ET Nyxoah SA Nyxoah or the
Read at benzinga.com
 |
Nyxoah Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Nyxoah can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Nyxoah Fundamental Analysis
We analyze Nyxoah's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nyxoah using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nyxoah based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Nyxoah is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Nyxoah Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nyxoah stock to make a market-neutral strategy. Peer analysis of Nyxoah could also be used in its relative valuation, which is a method of valuing Nyxoah by comparing valuation metrics with similar companies.
Peers
Nyxoah Related Equities
| MLSS | Milestone Scientific | 6.56 | ||||
| NXGL | Nexgel | 3.66 | ||||
| ATRC | AtriCure | 2.20 | ||||
| PDEX | Pro Dex | 0.50 | ||||
| INFU | InfuSystems Holdings | 0.37 | ||||
| KRMD | Repro Med | 0.24 | ||||
| UTMD | Utah Medical | 0.13 | ||||
| MMSI | Merit Medical | 1.01 | ||||
| DXR | Daxor | 1.24 | ||||
| LMAT | LeMaitre Vascular | 1.72 | ||||
| ZJYL | JIN MEDICAL | 4.35 |
Complementary Tools for Nyxoah Stock analysis
When running Nyxoah's price analysis, check to measure Nyxoah's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nyxoah is operating at the current time. Most of Nyxoah's value examination focuses on studying past and present price action to predict the probability of Nyxoah's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nyxoah's price. Additionally, you may evaluate how the addition of Nyxoah to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |